医学
重症监护医学
镰状细胞性贫血
药品
贫血
疾病
药理学
内科学
作者
Yogindra Persaud,Alexis Leonard,Parul Rai
标识
DOI:10.1080/14728214.2024.2379260
摘要
Since its discovery in the early 1900s, sickle cell disease (SCD) has contributed significantly to the scientific understanding of hemoglobin and hemoglobinopathies. Despite this, now almost a century later, optimal medical management and even curative options remain limited. Encouragingly, in the last decade, there has been a push toward advancing the care for individuals with SCD and a diversifying interest in options to manage this disorder.
科研通智能强力驱动
Strongly Powered by AbleSci AI